SG Americas Securities LLC Has $60,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

SG Americas Securities LLC raised its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 39.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,360 shares of the company’s stock after acquiring an additional 7,417 shares during the quarter. SG Americas Securities LLC’s holdings in Stereotaxis were worth $60,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in STXS. Jane Street Group LLC grew its position in shares of Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after buying an additional 6,313 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after buying an additional 15,491 shares during the period. State Street Corp grew its position in shares of Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after buying an additional 36,518 shares during the period. Barclays PLC grew its position in shares of Stereotaxis by 449.9% during the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Stereotaxis by 7.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock worth $2,840,000 after buying an additional 93,253 shares during the period. Institutional investors and hedge funds own 45.35% of the company’s stock.

Stereotaxis Stock Up 5.6 %

Shares of NYSEAMERICAN STXS opened at $2.27 on Friday. The company has a market cap of $192.34 million, a P/E ratio of -8.11 and a beta of 1.54. Stereotaxis, Inc. has a 52-week low of $1.66 and a 52-week high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last announced its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. The company had revenue of $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. As a group, equities research analysts predict that Stereotaxis, Inc. will post -0.26 earnings per share for the current year.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.